Study Reveals Cholesterol Loss During Myelin Damage May Impair Repair in Neurological Diseases
Researchers used mass spectrometry to quantitatively measure cholesterol levels in mouse brains and spinal cords across stages of myelination, demyelination, and remyelination. Cholesterol, which is concentrated in the myelin sheath, was significantly reduced during demyelination and failed to recover to normal levels even after remyelination, suggesting disrupted cholesterol synthesis. The findings may help identify therapeutic targets for promoting myelin repair in diseases like multiple sclerosis.
A new preprint study published on bioRxiv used gas chromatography-mass spectrometry (GC-MS-SIM) and liquid chromatography mass spectrometry (LC-MS) to track free cholesterol and cholesterol ester levels longitudinally in a genetic mouse model across postnatal myelination, demyelination, and remyelination. In healthy mice, brain cholesterol continued rising through 38 weeks, while spinal cord cholesterol stabilized after early postnatal growth. Cholesterol esters — a form associated with myelin damage — were notably high in the spinal cord at birth but dropped sharply by postnatal day 42. During peak demyelination, cholesterol esters rose dramatically, comprising 19% of total cholesterol in the brain and 65% in the spinal cord. Critically, cholesterol levels did not return to normal during remyelination, pointing to a persistent disruption in de novo cholesterol synthesis. The authors argue that absolute quantification of CNS cholesterol is essential for understanding disease mechanisms and developing strategies to restore myelin. The study has not yet undergone peer review.
What's missing
The study uses a single genetic mouse model, and it is unclear how well these findings translate to human neurological diseases such as multiple sclerosis. Additionally, the mechanisms by which de novo cholesterol synthesis is disrupted — and whether restoring cholesterol levels would functionally improve remyelination — remain open questions not addressed by this study.
What different sources said
- bioRxivCenter
Quantitative determination of longitudinal CNS cholesterol loss during myelin damage and repair
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.